MiRus is a life sciences company that has developed and is commercializing proprietary novel biomaterials, implants and procedural solutions for the treatment of spine, orthopaedic and structural heart disease.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/27/21 | $65,000,000 |
Mammoth Scientific | undisclosed |
